Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease

Clinical and Experimental Allergy

Volumn 46, Issue 2, 2016, Pages 317-328

  Acciani, T H ^a,b   Suzuki, T ^a,b   Trapnell, B C ^a,b   Le Cras, T D ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic asthma; EGFR; GM CSF; House dust mite; IL 17A

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AIRWAY EPITHELIAL CELL; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; ENZYME ACTIVITY; EPITHELIUM CELL; GOBLET CELL; HUMAN; HUMAN CELL; LUNG MECHANICS; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; ASTHMA; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; METABOLISM; PYROGLYPHIDAE; RESPIRATORY MUCOSA; RESPIRATORY TRACT ALLERGY; WESTERN BLOTTING;

ANIMALS; ASTHMA; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-17; MICE; PYROGLYPHIDAE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84955569946     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12612     Document Type: Article

References (54)

1. Bateman ED, Hurd SS, Barnes PJ etal. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
2. Barnes PJ. Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 2012; 129:48-59.
3. Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011; 242:205-19.
4. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-92.
5. Heijink IH, Nawijn MC, Hackett T-L. Airway epithelial barrier function regulates the pathogenesis of allergic asthma. Clin Exp Allergy 2014; 44:620-30.
6. Daniels SE, Bhattacharrya S, James A etal. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383:247-50.
7. Wang X, Saito J, Ishida T, Munakata M. Polymorphism of egfr Intron1 is associated with susceptibility and severity of asthma. J Asthma 2006; 43:711-5.
8. Monick MM, Cameron K, Staber J etal. Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 2005; 280:2147-58.
9. Koff JL, Shao MXG, Ueki IF, Nadel JA. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1068-75.
10. Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 2010; 6:e1001099.
11. Cao D, Tal TL, Graves LM etal. Diesel exhaust particulate-induced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 292:L422.
12. Amishima M, Munakata M, Nasuhara Y etal. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998; 157:1907-12.
13. Puddicombe SM, Polosa R, Richter A etal. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB 2000; 14:1362-74.
14. Polosa R, Puddicombe SM, Krishna MT etal. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J Allergy Clin Immunol 2002; 109:75-81.
15. Yamanaka Y, Hayashi K, Komurasaki T, Morimoto S, Ogihara T, Sobue K. EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem Biophys Res Commun 2001; 281:373-7.
16. Le CT, Acciani TH, Mushaben EM etal. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am J Physiol Lung Cell Mol Physiol 2011; 300:414-21.
17. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2001; 2:85-9.
18. Takeyama K, Fahy JV, Nadel JA. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001; 163:511-6.
19. Hur GY, Lee SY, Lee SH etal. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med 2007; 39:367-75.
20. Tamaoka M, Hassan M, McGovern T etal. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J 2008; 32:1213-23.
21. Vargaftig BB, Singer M. Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol 2003; 285:L808-18.
22. Al-Ramli W, Préfontaine D, Chouiali F etal. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123:1185-7.
23. Saha S, Doe C, Mistry V etal. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009; 64:671-6.
24. Yamashita N, Tashimo H, Ishida H etal. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell Immunol 2002; 219:92-7.
25. Cates EC, Fattouh R, Wattie J etal. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol 2004; 173:6384-92.
26. Hamilton JA, Anderson GP. GM-CSF biology. Growth Factors 2004; 22:225-31.
27. Mascia F, Cataisson C, Lee T-C etal. EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor invitro and invivo. J Invest Dermatol 2010; 130:682-93.
28. King C, Brennan S, Thompson PJ, Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 1998; 161:3645-51.
29. Laan M, Prause O, Miyamoto M etal. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-a. Eur Respir J 2003; 21:387-93.
30. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 2006; 177:4064-71.
31. Adam E, Hansen KK, Astudillo Fernandez O etal. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 2006; 281:6910-23.
32. Sahin U, Weskamp G, Kelly K etal. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164:769-79.
33. Xu P, Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell 2010; 37:551-66.
34. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. Well-differentiated human airway epithelial cell cultures. Methods Mol Med 2005; 107:183-206.
35. Huffman Reed JA, Rice WR, Zsengelle ZK, Wert SE, Dranoff G, Whitsett JA. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol 1997; 273:L715-25.
36. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001; 15:557-67.
37. Ying S, Robinson DS, Varney V etal. TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy 1991; 21:745-50.
38. Bradding P, Roberts JA, Britten KM etal. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
39. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008; 121:5-10.
40. Berry MA, Hargadon B, Shelley M etal. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354:697-708.
41. Erin EM, Leaker BR, Nicholson GC etal. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 2006; 174:753-62.
42. Wenzel SE, Barnes PJ, Bleecker ER etal. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 2009; 179:549-58.
43. Morjaria JB, Chauhan AJ, Babu KS, Polosa R, Davies DE, Holgate ST. The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 2008; 63:584-91.
44. Ober C, Thompson EE. Rethinking genetic models of asthma: the role of environmental modifiers. Curr Opin Immunol 2005; 17:670-8.
45. Vyalov S, Desmoulière A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch B Cell Pathol 1993; 63:231-9.
46. Park CS, Choi YS, Ki SY etal. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 1998; 12:872-8.
47. Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A. Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J 2014; 44:513-22.
48. Herbst R. Erlotinib (Tarceva): an update on the clinical trial program. Semin Oncol 2003; 30:34-46.
49. Nair JR, Edwards SW, Moots RJ. Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. Expert Opin Biol Ther 2012; 12:1661-8.
50. Fukumoto J, Harada C, Kawaguchi T etal. Amphiregulin attenuates bleomycin-induced pneumopathy in mice. Am J Physiol Lung Cell Mol Physiol 2010; 298:L131-8.
51. Okumura S, Sagara H, Fukuda T, Saito H, Okayama Y. Fcepsilon RI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J Allergy Clin Immunol 2005; 115:272-9.
52. Monticelli LA, Sonnenberg GF, Abt MC etal. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
53. Enomoto Y, Orihara K, Takamasu T etal. Tissue remodeling induced by hypersecreted epidermal growth factorand amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol 2009; 124:913-20.e7.
54. Kyung WK, Hye MJ, Yeo HP, Bong SC, Myung HS, Kim KE. Relationship between amphiregulin and airway inflammation in children with asthma and eosinophilic bronchitis. Chest 2009; 136:805-10.